Table 3.
Histopathological reassessment n (%)
| Parameter (n = 28) | Drug-induced colitis without atherosclerosis | Drug-induced colitis with atherosclerosis | Ischaemic colitis |
| Oedema | 2 (7.1) | 2 (7.1) | 4 (14.3) |
| Haemorrhage | 1 (3.6)a2 | 8 (28.6)a1 | 6 (21.4) |
| Lymphocytic infiltration | 27 (96.4) | 27 (96.4) | 27 (96.4) |
| Granulocytic infiltration | 27 (96.4) | 26 (92.9) | 28 (100.0) |
| Eosinophilic infiltration | 12 (42.9)b2 | 7 (25.0) | 1 (3.6)a3 |
| Erosions | 2 (7.1)b2 | 9 (32.1)a1 | 10 (35.7) |
| Ulcerous lesions | 4 (14.3)b2 | 3 (10.7) | 16 (57.1)b3 |
| Necrosis | 1 (3.6)b2 | 1 (3.6) | 16 (57.1)b3 |
| Fibrin plaques on erosions | 2 (7.1) | 2 (7.1) | 3 (10.7) |
| Fibrosis | 3 (10.7) | 3 (10.7) | 7 (25.0) |
1
Drug-induced colitis without atherosclerosis vs drug-induced colitis with atherosclerosis.
2
Drug-induced colitis without atherosclerosis vs ischaemic colitis.
3
Drug-induced colitis with atherosclerosis vs ischaemic colitis.
a
P < 0.05.
b
P < 0.01.
Statistical analysis was carried out with χ2 test.